You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly.
Go to headerGo to navigationGo to searchGo to contentsGo to footer
In content section. Select this link to jump to navigation

Exploring Network Properties Across Preclinical Stages of Alzheimer’s Disease Using a Visual Short-Term Memory and Attention Task with High-Density Electroencephalography: A Brain-Connectome Neurophysiological Study

Abstract

Background:

Visual short-term memory (VSTMT) and visual attention (VAT) exhibit decline in the Alzheimer’s disease (AD) continuum; however, network disruption in preclinical stages is scarcely explored.

Objective:

To advance our knowledge about brain networks in AD and discover connectivity alterations during VSTMT and VAT.

Methods:

Twelve participants with AD, 23 with mild cognitive impairment (MCI), 17 with subjective cognitive decline (SCD), and 21 healthy controls (HC) were examined using a neuropsychological battery at baseline and follow-up (three years). At baseline, the subjects were examined using high density electroencephalography while performing a VSTMT and VAT. For exploring network organization, we constructed weighted undirected networks and examined clustering coefficient, strength, and betweenness centrality from occipito-parietal regions.

Results:

One-way ANOVA and pair-wise t-test comparisons showed statistically significant differences in HC compared to SCD (t (36) = 2.43, p = 0.026), MCI (t (42) = 2.34, p = 0.024), and AD group (t (31) = 3.58, p = 0.001) in Clustering Coefficient. Also with regards to Strength, higher values for HC compared to SCD (t (36) = 2.45, p = 0.019), MCI (t (42) = 2.41, p = 0.020), and AD group (t (31) = 3.58, p = 0.001) were found. Follow-up neuropsychological assessment revealed converge of 65% of the SCD group to MCI. Moreover, SCD who were converted to MCI showed significant lower values in all network metrics compared to the SCD that remained stable.

Conclusion:

The present findings reveal that SCD exhibits network disorganization during visual encoding and retrieval with intermediate values between MCI and HC.

INTRODUCTION

Alzheimer’s disease (AD) is characterized by progressive cognitive impairment and behavioral changes with high socioeconomical impact [1]. In the preclinical stages of AD, such as mild cognitive impairment (MCI) or subjective cognitive decline (SCD), memory difficulties are generally apparent in tasks that require complex thinking, episodic memory, learning, or retention of visual and verbal information [2–7]. In particular, SCD is clinically defined as self-perceived changes in memory and cognition that individuals report in the absence of objective evidence of abnormality in clinical and neuropsychological evaluation. It is increasingly recognized as a risk factor both for MCI and AD compared to demographically matched healthy elders (hazard ratio 4.5) [4, 8–11]. SCD remains poorly explored with respect to the integrity of a wide array of brain functions and with a continuing debate regarding its clinical, research, and everyday utility [4, 12–14]. Therefore, it is imperative to seek and identify measurable indices and tools to detect indicative characteristics, patterns, causality, indicators, and factors in order to forestall both SCD and MCI [15, 16].

Meanwhile, technology and neuroimaging tools promise to provide more efficient and objective measurements as opposed to time- and effort-consuming neuropsychological assessment and interviews. In this light, the so-called “digital biomarkers” are emerging from the analysis of data streams from both lifestyle and biomedical technologies, including wearable and traditional electroencephalography (EEG) technology. The ongoing ‘Remote Assessment of Disease and Relapse–Alzheimer’s Disease’ (RADAR-AD, https://www.radar-ad.org/) international study uses remote monitoring technologies (RMTs) to continuously and objectively monitor functional decline in AD. This paper explores EEG analysis as a means for efficient and reliable assessment using technology, in the context of the RADAR-AD study. Remote monitoring technologies in the RADAR-AD study utilizes wearable and smart home devices as well as applications, used both at participant homes and during laboratory trials. The RADAR-AD study highlights the importance of efficient and reliable assessment using technology in such international studies. Motivated by the fact that portable EEG headbands will be used in RADAR-AD home trials, this paper explores the potential of EEG analysis obtained in a lab environment to be later transferred and compared to portable EEG applications at home.

Visual attention and short-term memory as indicators of cognitive impairment

A hallmark of aging widely observed in older-old adults is a decline in visual short-term memory and visual attention [17–20]. It refers to the ability to maintain the focus of cognitive activity over time on a given task and to preserve in mind a visual representation after the sensory stimulus has been disappeared [21, 22]. In particular, visual attention highly interacts with the encoding process of memory implementation [23], which utilizes neural circuits tailored for sensory perception and long-term memory retrieval [21, 24–27]. By this account, after the visual sensory input has been removed from sight, visual short-term memory is implemented by prolonged activations, through visual attention, of the same parietal and occipital brain areas which are supposed to evoke visual perception [28–31]. Visual short-term memory and attention are distinct yet interrelated processes and hold great scientific interest for AD research as precursors of cognitive decline related to AD. Cognitive mechanisms and neural activity underlying these tasks show a large degree of overlap. Therefore, the examination of these cognitive processes in a clinical setting in general or during brain activity recording in particular could indicate early disruption mechanisms related to dementia pathology and future progression. Especially activity within the posterior parietal cortex reflects object maintenance across distraction or sustained attention per se, it is necessary to control for attentional demands inherent in VSTM tasks. During this process, parietal and occipital regions play pivotal role [32–37], whereas the prefrontal cortex does not constitute a particular brain region for memory storage [29, 38]. Thus, plenty of findings, even with single-unit recordings, have provided substantial information with regards to the control of visual processing and stimulus selection in the visual cortex over the parietal cortices [39–49].

Previous studies have shown that AD as well as MCI patients frequently demonstrate deficits on visual attention and visual short-term memory and can be characterized by significant abnormality [50–55]. The deficits relate to reduced white matter integrity [56, 57], worse performance of daily activities, and lower quality of life [53, 58–60]. Electrophysiological studies employing the computational theory of visual attention [61, 62] have found also decreased visual short-term memory storage capacity in elders compared to younger adults [18, 63–66]. Moreover, several neuroimaging studies have identified interrupted connections, basically located over the superior longitudinal and inferior fronto-occipital fasciculus, the parietal and frontal eye field regions, and corpus callosum, which has been found to be responsible for visuospatial dysfunction in cases of brain damage [67, 68].

Recent studies underline the principle involvement of posterior parietal cortices (PPC) in visual short-term memory [30, 69], given that create mental images, while combining sensory and motor inputs. Therefore, the activity in the PPC is highly correlated with the proportion of scene-related information and mental representations that can be stored in visual short-term memory [30]. Functional changes in early stages of AD are located over the posterior hemispheres rather than the frontal areas of the brain [32–37]. Studies highlight the pivotal role of the PPC, visual and prefrontal cortices, a key neural factor of the mental representation of the visual world in attention [68, 70–76]. In particular, the PPC might act as a capacity-limited store for the representation of the visual scene, while pieces of evidence suggest that item location and identification are in generally taken place in dorsal (occipito-parietal) and ventral (occipito-temporal) cortical visual areas, respectively [44]. As a result, impairment in attentional mechanisms related to divide and sustain attention has been related to impaired visuospatial memory function in older-old adults [53, 77–80]. Finally, pieces of evidence have showed that visuospatial decline is linked to reduced bilateral parietal and right temporo-parietal metabolism in mild to moderate AD [81]. Despite this body of work, research focusing on associations between brain activation and visual short-term memory and visual attention performances among people with MCI and SCD is still in its infancy.

Brain connectome in preclinical stages of AD continuum

Investigating human brain connectome, based on graph theory, can improve our understanding of the complex organization of the human brain [82–85]. Recent findings underline that subtle connection between different brain regions, showing reduced functional connectivity (FC), constitutes the substrate of the AD pathophysiological mechanisms [86]. Evidences shows that AD is associated with alteration of FC among different brain regions [87–90]. Specifically, it has been shown that AD patients have decreased FC between regions in the hippocampus, in prefrontal lobe and medial frontal, parietal and posterior cingulate cortex, and between the two lobes [91, 92]. In detail, FC abnormalities have been described as a disconnection syndrome and have been widely reported in preclinical stages, such as MCI and SCD, as well [57, 93–95]. Thus, they promise great utility in predicting future transition to more advanced stages of cognitive decline and conversion to AD [96, 97]. Despite the fact that resting state has been already investigated in SCD population, brain connectome during memory and attentional performance is scarcely explored [98–100].

Our recent review [94] suggested that SCD may actually demonstrate intermediate changes between healthy elders and MCI at a network level of the brain and implies that brain connectome could be considered as a potential biomarker of predicting future cognitive deterioration associated with AD. However very limited studies have so far explored the brain network in SCD using EEG [93, 94]. In the majority of the included studies, SCD exhibited lower values compared to healthy controls with regards to local efficiency, network strength, and shortest path length but preserved global network properties such as small-world and rich-club. On the other hand, local network metrics like degree, shortest path length, clustering coefficient, etc., revealed the subtle connectivity issues in spatial, functional, and structural changes in particular brain areas in SCD compared to HC. Nevertheless, studies based on EEG have revealed that MCI subjects displayed a significant decrease in alpha power, a slowing of the EEG, a reduced complexity of the EEG signals, and perturbations in the EEG synchrony compared to normal elderly people [101–104]. Furthermore, it has been reported that there is a prominent decrease in the functional coupling of EEG rhythms in AD and MCI compared to normal elderly subjects [105–109]. Therefore, the investigation of the complex brain mechanisms holds great scientific interest for the SCD using FC patterns, against those of more advanced stages. So far, the knowledge about the course of FC alterations in the SCD is really scarce [110, 111], while the exploration of FC in SCD using high density EEG is still limited [93, 94].

Study aim

The present study constitutes a novel research that focuses on investigating brain connectivity abnormalities and network metrics [112] (Clustering Coefficient, Strength, and Betweenness Centrality) at the occipito-parietal area throughout preclinical stages of AD by implementing High Density-Electroencephalography (HD-EEG, EGI GES 300) during a visual attention (VAT) and a short-term memory task (VSTMT). We have constructed correlation matrices and weighted undirected networks to precisely detect brain network properties across the four groups and compare the results with standard neuropsychological tests. In light of previous research findings [93, 94], our expectation in this study was to find differences in network properties among SCD individuals with regards to HC. In particular, we hypothesized that the SCD group would exhibit brain changes and network interruption in a similar way to those displayed in MCI, although to a lower extent, yielding in an intermediate stage between HC and MCI [93, 94]. To the best of our knowledge, there is no existing study that has explored the potential of these particular network metrics in SCD population during VAT and VSTMT with HD-EEG [94]. Therefore, our study aimed to: 1) compare VSTMT and VAT performances between HC and people with SCD, people diagnosed with MCI and AD by standardized neuropsychological tests at baseline and after three years, and 2) examine the clinical relevance between visual short-term memory and visual attention performances with the parameters of the brain network, so as to improve our understanding of factors contributing to the signs and symptoms of SCD.

MATERIALS AND METHODS

Settings and participants

In total 80 participants were recruited from the memory & dementia clinic of the 1st Department of Neurology, U.H. AHEPA, Aristotle University of Thessaloniki, Greece (https://www.med.auth.gr/) and the Greek Association of Alzheimer’s Disease and Related Disorders (GAADRD; https://www.alzheimer-hellas.gr/index.php/el/). The study was carried out in accordance with the Declaration of Helsinki, has received approval by the Scientific & Ethic committee of GAADRD (No 41/6-6-2018), while a written informed consent was obtained from all participants prior to their participation in the study. The diagnosis of HC, SCD, MCI, and AD was set by a neuropsychiatrist (MT) according to the structural magnetic resonance imaging (MRI), medical history, neuropsychological tests, and neurological examination. Upon initial processing, we identified that the EEG data of seven individuals were highly contaminated by both head and eye movement artifacts. This can be explained due to the nature of the experiment that constitutes several participants to ask the experiment to help them. Hence, they were excluded from the signal analytic EEG pipeline, yielding 73 participants for the final results in the study.

In detail, the SCD group consisted of 17 participants, the MCI group consisted of 23 participants, the AD group consisted of 12 participants, while 21 HC were also included having similar range of ages and education. The participants in all four groups were over 60 years old [113–115]. Table 1 presents the average age with the standard deviation for each group of participants. Participants with AD fulfilled the National Institute of Neurological and Communication Disorders and Stroke/Alzheimer’s Disease and Related Disorders Association (NINCDS-ADRDA) criteria for probable AD [116], as well as the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) criteria for dementia of Alzheimer type (APA, 1994). On the other hand, the MCI participants fulfilled the Petersen criteria [117], while the SCD group met IWG-2 Guidelines [118] as well as the SCD-I Working Group instructions [119]. More specifically, the criteria for recruiting SCI participants were in accordance with the latest suggestions proposed by the SCD-I Working Group [119], while for the participants of the other groups the respective above mentioned criteria were followed. Moreover, we would like to make clear that with regards to our study, the identification of SCD participants further included self-perceived memory decline compared to other cognitive functions and in reference to others of the same age occurring during the past five years as determined by the individuals’ medical history and an informant report, at an age cut-off of 60. Regarding the preclinical stage of SCD, we tried to eliminate possible confounding factors based on blood tests (hormonal disorders, vitamin deficiency, etc.) and structural MRI (vascular/demyelinating lesions, tumors, anatomical variations, etc.). All the above were taken under consideration for the recruitment process, since they could affect our sample performance and signal elicitation. Additional inclusion criteria for the SCD and HC subjects were to have a normal general medical, neurological, and neuropsychological examination. Exclusion criteria included 1) severe psychiatric, physical, or other neurological disorder illness or any other somatic disorder which may cause cognitive impairment, 2) history of alcohol or drug and use of neuromodifying drugs except cholinesterase inhibitors or memantine for the AD patients, and 4) left handedness.

Table 1

Mean±SD (standard deviation) and p value of demographic characteristics of participants (HC = 21, SCD = 17, MCI = 23, AD = 12)

HCSCDMCIADp
Demographics
Age62.62 (13.86)66.82 (8.20)69.61 (6.91)70.50 (7.69)0.734
Gender (M:F)8:136:117:164:80.522
Years of Education14.70 (5.32)12.76 (4.77)10.08 (4.36)9.78 (3.96)0.253

Neuropsychological assessment

All participants underwent a detailed neuropsychological evaluation at baseline, where the EEG recording took place and after 3 years (follow-up), which included the same standardized neuropsychological battery, an insightful psychological interview and medical history using the Structured Clinical Interview for DSM-IV Axis I Disorders Clinical Version (SCID-CV) [120], as well as physical and neurological examination. In particular, the following neuropsychological battery was implemented in order to assess cognitive status comprehensively and evaluate aspects like working memory, executive functioning, attention, memory and language: a) the Greek version of Mini-Mental State Examination (MMSE) [121], b) Functional Rating Scale for Dementia (FRSSD) [122], c) Functional and Cognitive Assessment Test (FUCAS) [123], d) Trail Making Test part-B [124], e) RBMT-story Direct and delayed recall [125], f) Rey Osterrieth Complex Figure Test copy and delay recall (ROCFT-copy and delayed recall) [126], g) Rey Auditory Verbal Learning Test (RAVLT), and h)Verbal Fluency test (FAS). Evaluation of mood and behavior took place both from the interview data and the participant and caregiver answers to the relative brief self-report tools, the Neuropsychiatric Inventory (NPI) [127] and the Perceived Stress Scale (PSS) [128].

Notably, in each of the neuropsychological tests we used to test the cognitive performance of the four groups, the performance of all subjects in HC and SCD was indicative of normal cognitive status (Table 1). In other words, the aforementioned neuropsychological tests are only capable of distinguishing between normal and abnormal cognitive status and lacks the sensitivity necessary to classify a subject as HC or SCD. This is not the case for the other groups, since according to the One-way ANOVA test, used to investigate differences between our four groups, the MCI and AD group showed statistically significant worse performance scores in the majority of MMSE, FRSSD, FUCAS, RAVLT, FAS, ROCFT, and RBMT memory tests. In Table 2, superscripts indicate when the difference between two groups is statistically significant using the independent sample t-test. Table 2 presents the mean values and standard deviation in the baseline, the follow-up neuropsychological assessment, and the SCI and MCI who converted to more advanced stages after three years.

Table 2

Mean±SD (standard deviation) and p value of one-way ANOVA of neuropsychological assessment at baseline and follow-up among participants and those who converged in follow-up (HC = 21, SCD = 17, MCI = 23, AD = 12)

HCSCDMCIADp
BaselineFollow-UpBaselineFollow-UpConvergedBaselineFollow-UpConvergedBaselineFollow-UpBaselineFollow-Up
MMSE29.29 (1.38)28.08 (2.19)28.53 (0.87)27.38 (1.38)27.09 (1.30)26.22 (2.08)*26.00 (2.63)*23.66 (3.05)20.67 (5.48)**9.20 (9.00)**0.00010.0001
NPI0.70 (1.78)2.00 (2.73)1.71 (3.07)1.84 (3.43)2.18 (3.65)2.50 (3.78)1.62 (3.24)6.33 (5.68)9.42 (10.13)19.00 (18.76)**0.00010.0001
FRSSD total score3.94 (1.92)3.16 (1.33)4.14 (2.49)3.307 (2.59)3.36 (2.50)5.71 (8.59)4.25 (2.43)8.33 (1.52)8.50 (5.74)20.20 (11.51)**0.1090.0001
FUCAS total score42.05 (9.56)42.91 (1.44)43.65 (1.99)43.84 (2.07)43.90 (2.16)45.45 (4.54)*45.81 (3.33)49.33 (5.77)57.92 (15.20)**92.20 (30.57)**0.00010.0001
TRAIL-B133.20 (269.14)166.10 (49.69)146.69 (86.66)186.69 (62.96)202.54 (54.27)160.88 (60.47)248.30 (110.88)*467.00240.06 (133.97)**0.00 (0.00)**0.1540.048
RBMT-immediate recall13.063 (3.79)17.42 (5.39)12.250 (3.37)12.54 (3.73)18.77 (27.56)11.306 (3.29)10.28 (3.25)5.005.150 (4.35)**2.37 (2.75)**0.00010.305
RBMT-delayed recall12.938 (6.90)11.95 (4.49)11.375 (3.22)8.88 (4.59)9.63 (4.08)10.028 (3.86)7.96 (4.56)5.002.95 (4.06)**0.12 (0.25)**0.00010.001
ROCFT-copy32.125 (4.11)31.38 (2.59)33.844 (2.11)30.27 (2.59)31.27 (2.83)29.556 (6.74)28.50 (7.32)*17.0021.85 (9.11)**7.25 (13.84)**0.00010.0001
ROCFT-delayed recall19.456 (8.41)16.22 (7.46)19.000 (7.94)14.38 (7.79)14.72 (8.34)15.472 (6.68)13.38 (7.67)*7.006.40 (6.74)**1.00 (2.00)**0.00010.005
RAVLT 16.56 (2.25)6.54 (2.54)5.63 (2.06)5.69 (1.75)6.45 (2.20)5.67 (1.45)5.6923 (2.49)*5.58 (1.62)3.90 (1.52)**2.00 (1.63)**0.0100.013
RAVLT 211.38 (15.94)8.81 (3.48)6.75 (4.12)6.84 (2.51)6.64 (4.05)5.33 (2.59)6.07 (3.20)5.35 (2.46)2.60 (2.84)**1.75 (1.25)**0.0760.002
FAS10.4600 (3.15)12.13 (4.05)12.4240 (3.43)12.54 (3.12)11.73 (2.38)10.2756 (3.84)6.90 (3.39)*7.00 (3.36)6.407 (3.43)**0.00 (0.00)**0.0010.043

*HC versus MCI –p < 0.05. **HC versus AD –p < 0.01. HC versus SCD –p < 0.05.

Visual attention and short-term memory task (VAT & VSTMT) and EEG recording

For this research, participants had to fulfil one task involving visual attention and short-term memory. The task began with a 5-point calibration procedure, to correctly map eye position onto screen coordinates and written instructions were given to participants. In total, 22 images containing landscapes or events were used and a multiple-choice question, relating to the image, followed immediately after the image disappeared. Each trial began with a fixation circle, which remained on the screen for 1 s. Each image was afterwards projected for 20 s and subjects were instructed to pay particular attention to the images and its items (VAT). After the presentation, the fixation circle was presented and then the question followed (VSTMT). Participants were asked to respond to a question relevant to the image as quickly as possible and proceed to the following. Two examples were given in the beginning, to help subjects familiarize with the experiment. The whole procedure was divided into two blocks, each one consisting of 11 images and a 1-min break between them. The total duration was approximately 12 min. The whole process is illustrated in Fig. 1.

Fig. 1

EEG, Eye-Tracker Set-Up, and VAT & VSTMT process timeline

EEG, Eye-Tracker Set-Up, and VAT & VSTMT process timeline

EEG data acquisition and network construction

Regarding the data acquisition, we have followed the same protocol as we did in our previous research efforts [93]. Figure 2 illustrates the pipeline process for data acquisition, construction of the weighted undirected networks, and extraction of the metrics derived from the Correlation Matrices of the EEG, during VSTMT and VAT. HD-EEG data were recorded with the EGI 300 Geodesic EEG system (GES300) using a 256-channel HydroCel Geodesic Sensor Net (HCGSN) and a sampling rate of 250 Hz (EGI Eugene, OR). Moreover, the researcher placed the electrodes in accordance with the ‘256 HCGSN adult 1.0’ montage system, while the signals were recorded relative to a vertex reference electrode (Cz) and with AFz as the ground electrode. The impedance was kept for all electrodes below 50  kΩ throughout the experimental procedure as recommended for the high-input impedance amplifier [129]. The SMI Red500 (SensoMotoric Instruments) eye-tracker was used to generate gaze maps and ensure the sustained attention of the participants while avoiding fatigue. The experiment was projected on a 22” monitor and the tasks were developed using the Experiment Center software, powered by SMI. Subjects sat approximately 60 cm away from the monitor. HD-EEG data were initially filtered with a 5th-order bandpass Butterworth IIR filter of 0.3–70 Hz and then segmented using the task triggers timestamp and an epoch time of 1 s, including 100 ms pre-stimulus time. In addition, artefact detection and bad channel replacement was performed. Data were baseline-corrected using a 100 ms pre-stimulus period and the Net Station 4.3 software (EGI; https://m.egi.com/clinical-division/clinical-division-clinical-products/ges-300). We examined both tasks (VAT and VSTMT). Detection of “bad” segments was executed by marking those segments with amplitudes more than 100μV. Also, signals from the rejected (bad) electrodes were replaced using an interpolation process provided by the ‘bad channel replacement’ algorithm (Net Station 4.3). The brain network analysis was conducted at a first level in a personalized fashion, deriving the individual weighted correlation matrices upon all trials. Then the averaged profiles (i.e., averaged correlation matrices) were estimated for every group (HC, SCD, MCI, and AD) and were considered as the input matrices for the estimation of the network metrics. The Pearson Correlation Coefficient (PCC) was employed in order to measure connectivity between all pairs of electrodes. PCC is a measure of normalized covariance between two continuous variables that can be estimated by dividing the covariance of two variables by the product of their standard deviations. In this respect, the weighted correlation matrices were created using the PCC between the time series of each pair of electrodes (all electrodes at VAT and VSTMT, occipito-parietal electrodes). Besides the pre-processing steps performed using Net Station’s algorithms, all other processing and analysis steps were performed using Matlab 2019 (The Mathworks, Natick, USA).

Fig. 2

Outline of the experimental procedure and the methodology for extracting the network metrics derived from Correlation Matrices after VAT and VMT.

Outline of the experimental procedure and the methodology for extracting the network metrics derived from Correlation Matrices after VAT and VMT.

Occipito-parietal network analysis

We employed weighted correlation matrices from the EEG electrodes in order to analyze the undirected brain network and explore particular network metrics. In detail, we considered a local network of selected electrodes (parietal and occipital region), which is the most prominent choice for the examination of VAT and VSTMT [130–134]. Regarding the network, we chose the following electrodes according to the EGI system numbering: “66, 72, 75, 76, 77, 78, 84, 85, 86, 87, 88, 95, 97, 98, 99, 100, 101, 104, 105, 106, 107, 108, 109, 110, 112, 113, 114, 115, 116, 117, 118, 119, 121, 122, 123, 124, 125, 126, 127, 128, 129, 134, 135, 136, 137, 138, 139, 140, 141, 142, 146, 147, 148, 149, 150, 151, 152, 153, 154, 156, 157, 158, 159, 160, 161, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 175, 176, 177, 178, 179, 180, 188, 189, 200” [135], which represent the respective parietal and occipital areas. The corresponding electrodes of the EEG were considered to constitute the nodes of the graph [112], while the correlation between the nodes –electrodes (absolute value of PCC) represents the edges of the graph [136, 137]. More information about the position of the electrodes can be found in Electrical Geodesics Inc (2007) Geodesic Sensor Net Technical Manual (https://www.egi.com/research-division/geodesic-sensor-net). In this way, we constructed a weighted graph in order to analyze the brain network and explore the network metrics of clustering coefficient, strength and betweenness centrality. Whereas strength (S) quantifies aggregation and clustering coefficient (CC) segregation, we also considered the betweenness centrality (BC) as a measure of centrality [138]. Using the toolboxes of Brain Connectivity (https://brain-connectivity-toolbox.net) and FieldTrip (https://www.fieldtriptoolbox.org/), these network metrics were derived from the weighted adjacency matrices with the intention to characterize the connectivity properties of local occipito-parietal network. The details of these network metrics are briefly presented below.

Clustering Coefficient (CC)

Given a graph G of N nodes and weighted connections, the weighted clustering-coefficient CCv of node v provide us with a measure of interconnection between node v and its neighbors, where Nv is the number of links between neighbors of v and Kv its degree [138].

(1)
CCv=2NvKv-1

Strength (S)

The connection strength Sk of each node k in the graph is estimated as the sum of the weights of all the connections of node k, gaining information on the total level of (weighted) connectivity of a node [138]. The strength expresses how strongly the node is connected with its neighboring nodes, by summing all weights of the connections of this node. Strength equals to the sum of connectivity weights attached to a given node. It may serve, approximately, as a centrality measure, indicating the importance of the associated brain region within the observed network organization:

(2)
Sk=rkNWkr

Betweenness Centrality (BC)

The Betweenness Centrality BCv of a node v in the graph is related to the fraction of the total number of the shortest paths, that pass through node v from node s to node t (σst(v)), to the total number of the shortest paths from node s to node t (σst). BC describes the centrality of a graph using shortest paths and represents the degree to which nodes stand between each other. The total BC of the graph G is the average of all N node Betweenness Centralities:

(3)
BCv=svtσstVσst

Statistical analysis

We compared brain network data (in terms of PCC) among the four groups at the level of significance p = 0.05. Network metrics were compared between groups using ANOVA analysis. Statistical analysis was performed using SPSS v25.0 for Windows (IBM Corporation, Armonk, NY, USA). For assessing the normality assumption for continuous and categorical variables we used the Kolmogorov-Smirnov and chi-squared test, respectively. For examining the potential statistical significance between two independent groups (e.g., HC versus SCD), we used the independent sample t-test. Moreover, independent sample t-test was used for the years of education variable yielding no statistical difference among the groups, with p = 0.253, while no gender differences were found after Chi-Square analysis (p = 0.522). We used One-Way ANOVA in order to analyze the difference in the network metrics across the four groups both for VAT and VSTMT. In cases, where network metrics showed statistical significance between groups, within group differences were tested using the t-test. Correlation between neuropsychological tests and network-derived metrics was assessed by using PCC.

RESULTS

Comparison of network properties between HC, SCD, MCI, and AD

In order to compare the network properties of the different groups we have employed the following analysis: a) The mean and standard deviation of the averaged measured corresponding to the network metrics (Clustering Coefficient, Strength, and Betweenness Centrality) of each group and for each task (see Table 2 and Supplementary Figure 1). These are further complemented by the result of the one-way ANOVA test across the four groups and for each network metric and task, and the results of an independent sample t-test to evaluate the statistically significant difference between pairs of groups (superscripts are used to indicate the statistically significant difference between a pair of groups); b) Boxplots visualizing the separability of the four groups for each network metric and task (Fig. 3); and c) Topoplots generated from the correlation matrices for the three networks metrics for both tasks (VAT and VSTMT) (Fig. 4).

Fig. 3

Boxplots showing differences for the four groups of participants (HC = 21, SCD = 17, MCI = 23, AD = 12) in Clustering Coefficient, Strength, and Betweenness Centrality during VAT and VSTMT.

Boxplots showing differences for the four groups of participants (HC = 21, SCD = 17, MCI = 23, AD = 12) in Clustering Coefficient, Strength, and Betweenness Centrality during VAT and VSTMT.
Fig. 4

Topoplots for the three network metrics (clustering coefficient, strength and betweenness centrality during VAT (right) and VSTMT (left) across the four groups of participants (HC = 21, SCD = 17, MCI = 23, AD = 12).

Topoplots for the three network metrics (clustering coefficient, strength and betweenness centrality during VAT (right) and VSTMT (left) across the four groups of participants (HC = 21, SCD = 17, MCI = 23, AD = 12).

In Table 2, we can observe that the mean values of the HC are higher compared to the rest of the groups (i.e., SCD, MCI, and AD). Moreover, the results of the one-way ANOVA test show that there is statistically significant difference in several network metrics across the four groups of participants at level p = 0.05, such as: i) in VSTMT: CC: [F (3, 69) = 4.56, p = 0.006], S: [F (3, 69) = 4.76, p = 0.005], and BC: [F (3, 69) = 0.78, p = 0.510], and ii) VAT: CC: [F (3, 59) = 5.06, p = 0.003], S: [F (3, 69) = 5.40, p = 0.002], and BC: [F (3, 69) = 3.54, p = 0.019]. In addition, the results of the independent sample t-test indicate that statistically significant differences are also present between pairs of groups as described below:

VAT

According to Independent Sample t-test, CC was higher for HC (M = 0.71, SD = 0.12) compared to SCD (M = 0.62, SD = 0.09), t (36) = 2.43, p = 0.026, to MCI (M = 0.59, SD = 0.19), t (42) = 2.34, p = 0.024, and to AD group (M = 0.48, SD = 0.25), t (31) = 3.58, p = 0.001 as well. On the other hand, with regards to S, statistical analysis showed higher values for HC (M = 56.42, SD = 8.06) compared to SCD (M = 50.59, SD = 6.19), t (36) = 2.45, p = 0.019, to MCI (M = 48.91, SD = 11.97), t (42) = 2.41, p = 0.020, and to AD group (M = 40.77, SD = 16.74), t (31) = 3.58, p = 0.001. Finally, BC showed no statistically significant differences between HC and SCD or MCI but only between HC (M = 5.33, SD = 4.15) compared to AD (M = 1.97, SD = 0.82), t (31) = 2.75, p = 0.010 and SCD (M = 5.33, SD = 3.08) compared to AD (M = 1.97, SD = 0.82), t (27) = 3.67, p = 0.001.

VSTMT

Similar to VAT, according to Independent Sample t-test, CC was also higher for HC (M = 0.69, SD = 0.12) compared to SCD (M = 0.59, SD = 0.11), t (36) = 2.33, p = 0.025, to MCI (M = 0.59, SD = 0.15), t (41) = 2.43, p = 0.019 and to AD group (M = 0.48, SD = 0.24), t (31) = 3.25, p = 0.003 as well. Additionally, with regards to S, statistical analysis showed higher values for HC (M = 55.15, SD = 8.36) compared to SCD (M = 49.27, SD = 7.47), t (36) = 2.26, p = 0.030, MCI (M = 48.21, SD = 9. 71), t (41) = 2.44, p = 0.019, and AD group (M = 41.52, SD = 15.83), t (31) = 3.25, p = 0.003. On the other hand, with regard to BC, comparisons between the remainder of the groups revealed no statistically significant difference either between SCD versus MCI and AD or MCI versus AD.

In Fig. 3, we can observe increased FC (lower mean values in CC and higher mean S) in HC with regards to SCD, MCI, and AD participants, while lower mean values of BC have also been found in later stages of the disease.

Finally, in Fig. 4, we can see that HC group presents a denser network with several connections between nodes at occipito-parietal electrodes regarding CC and S. As the disease progresses, we can see more apparent connections between nodes during VAT and VSTMT (Fig. 4). The correlation differences are more obvious in the VAT. Especially in the case of AD the network connections are much more aberrant, while network interruption is widely observed over the occipito-parietal network.

Sensitivity and specificity of network properties

In this section, we investigate the potential utility of the abovementioned network properties for VAT and VSTMT as a marker to distinguish an individual’s cognitive condition (SCD, MCI, and AD) compared to HC by testing Sensitivity and Specificity among the groups (Table 3). More specifically, we examined the Area Under the Curve (AUC), as formed by drawing the curve of Sensitivity versus Specificity. These pieces of evidence can provide information about the use of CC, S, and BC as indicators that would distinguish SCD from the other conditions (and more importantly the HC from SCD) using objective measures. Specificity and Sensitivity values were estimated by using SPSS v25.0. In particular, we developed ROC curves and identified the best threshold of the network metrics to differentiate the groups. The Sensitivity and Specificity scores corresponding to the cutoff thresholds alongside with the AUC are shown in Table 4, while Fig. 5 visualizes the AUC, Sensitivity, and Specificity of the respective network metrics.

Table 3

Sensitivity and Specificity of Clustering Coefficient, Strength, and Betweenness Centrality at VAT and VSTMT for all different combinations between pair of groups

GroupsTaskNetwork PropertyAUC (%)Threshold ValueSensitivity (%)Specificity (%)
HC versus SCDVATClustering Coefficient710.627165
Strength7150.727165
Betweenness Centrality454.146241
VSTMTClustering Coefficient710.656765
Strength7052.846265
Betweenness Centrality516.322965
HC versus MCIVATClustering Coefficient670.705274
Strength6755.835274
Betweenness Centrality573.776761
VSTMTClustering Coefficient710.637161
Strength7051.766761
Betweenness Centrality594.775265
HC versus ADVATClustering Coefficient780.646267
Strength7848.748658
Betweenness Centrality752.247167
VSTMTClustering Coefficient770.626267
Strength7752.706267
Betweenness Centrality642.547658
SCD versus MCIVATClustering Coefficient480.624144
Strength4950.464144
Betweenness Centrality643.926565
VSTMTClustering Coefficient540.625357
Strength5349.975352
Betweenness Centrality564.295357
MCI versus ADVATClustering Coefficient670.616167
Strength6749.436167
Betweenness Centrality661.836167
VSTMTClustering Coefficient600.546150
Strength6146.606158
Betweenness Centrality522.166150
Table 4

Mean±SD of network properties during VAT and VMT across the four groups (HC = 21, SCD = 17, MCI = 23, AD = 12). The last column of the table shows the p-value of one-way ANOVA. Superscripts indicate the statistical significance between groups after independent sample t-test

HCSCDMCIAD
MeanSDMeanSDMeanSDMeanSDp
VATClustering Coefficient0.71*0.120.620.090.59***0.190.480.250.003
Strength56.42**8.0650.586.1948.91***11.9940.7716.740.002
Betweenness Centrality5.334.155.333.083.923.021.980.810.012
VSTMTClustering Coefficient0.69**0.120.600.110.59***0.150.490.240.006
Strength55.15**8.3649.277.4748.21***9.7141.52115.830.005
Betweenness Centrality4.642.494.513.063.872.713.362.110.531

*HC versus SCD - p < 0.05. **HC versus SCD –p < 0.01. ***HC versus MCI –p < 0.05. HC versus AD –p < 0.001.

Fig. 5

ROC Curves showing the Clustering Coefficient, Strength, and Betweenness centrality at VAT and VSTMT for discriminating between: A) SCD and HC, B) MCI and HC, C) AD and HC, D) MCI and SCD, E) SCD and AD, F) MCI and AD.

ROC Curves showing the Clustering Coefficient, Strength, and Betweenness centrality at VAT and VSTMT for discriminating between: A) SCD and HC, B) MCI and HC, C) AD and HC, D) MCI and SCD, E) SCD and AD, F) MCI and AD.

In detail, we manage to successfully discriminate HC from SCD using either the CC (Sensitivity = 75% and Specificity = 64%, AUC = 71%) or the S (Sensitivity = 75% and Specificity = 64%, AUC = 71%) measure during VAT and VSTMT. Also, we manage to discriminate HC from MCI using either the CC (Sensitivity = 64% and Specificity = 80%, AUC = 73%) or the S (Sensitivity = 80% and Specificity = 64%, AUC = 79%) measure during both tasks. Finally, HC also discriminated from AD using either the CC (Sensitivity = 65% and Specificity = 82%, AUC = 79%) or the S (Sensitivity = 65% and Specificity = 82%, AUC = 79%) both in VAT and VSTMT. None of the other simulation tests for BC did manage to yield a performance over the minimum value (AUC = 60%) both for Specificity and Sensitivity (Fig. 5). Consequently, although there are cases that we managed to surpass 60%, which indicates a good classification of patient groups, there is still work to do for reaching a clinically meaningful and a highly robust level of discrimination between groups that will allow the adoption of these metrics by the clinicians.

Neuropsychological assessment and network properties

Neuropsychological assessment revealed no statistically significant difference between HC and SCD, whereas significant difference was found between HC and the rest of the groups (MCI and AD) at baseline (Table 1). On the other hand, follow-up neuropsychological assessment after 3 years (Table 1) revealed significant changes in the cognitive performance of the SCD group since 35.3% remained at SCD stage and 64.7% converged to MCI. In addition, from the MCI group, 13% converged to AD and 78.2% remained at MCI group. On the other hand, from the HC group only 9.5% converged to MCI. Moreover, the SCD group who converted to MCI and MCI group who had further cognitive decline or converted to AD showed worse performance in the second neuropsychological examination compared to the baseline assessment (Table 1). Additionally, with regards to the network metrics, SCD who do converted to MCI had lower performance: i) in VSTMT: CC: (M = 0.57, SD = 0.12), S: (M = 47.80, SD = 7.73), and BC: (M = 4.19, SD = 3.16); ii) VAT: CC: (M = 0.62, SD = 0.11), S: (M = 50.73, SD = 7.03) and BC: (M = 4.86, SD = 3.30). On the other hand, the SCD that remained stable showed increased values i) in VSTMT: CC: (M = 0.72, SD = 0.11), S: (M = 57.29, SD = 7.03), and BC: (M = 4.35, SD = 2.70); ii) VAT: CC: (M = 0.68, SD = 0.10), S: (M = 54.93, SD = 6.14) and BC: (M = 3.58, SD = 0.51).

As seen in Table 1, statistically significant differences at baseline are mostly found between the group of HC compared to MCI (less frequent) and AD (in almost all tests), supporting the differentiation of MCI and AD compared to HC in a variety of cognitive domains (e.g., Daily functionality, Memory, Executive Function, etc.). However, as expected, in the case of patients with SCD, who are clinically and cognitively equal to HC, no significant differentiation was found between traditional neuropsychological tests at baseline, which motivates the need to explore other mechanisms for distinguishing between HC and SCD, given that both groups present similar cognitive profile and neuropsychological performance. Albeit, in the follow-up assessment after three years, statistically significant difference was found among the four groups and between the baseline and follow-up assessment in each group of SCD, MCI, and AD showing deterioration in global cognition, visuospatial ability, and episodic memory.

DISCUSSION

The present study presents the results of investigating brain connectome alterations in the preclinical stages of AD by using a HD-EEG during VSTMT and VAT. The evidence collected suggest the importance of brain network metrics extracted through EEG, for the characterization of a subject as SCD that is highly likely to convert to more advanced stages of AD and its connectivity mechanisms as a trigger of the dementia. Our study showed that SCD and MCI participants demonstrate interruptions both in visual attention and in short-term memory network compared to HC, showing the potential use of these networks to identify people that even though they still exhibit a normal neuropsychological profile, they are at risk of developing AD.

In more detail, the results showed that AD patients were always characterized by high impairment levels, while MCI and SCD patients had an intermediate performance compared to HC. In HC, increased CC and S over posterior regions has been found during VSTMT, presumably related to better encoding process during the attentional phase which yields subsequent better retrieval, whereas in SCD and MCI reduced CC and S over posterior regions was detected. According to the conditions and/or the measures considered, SCD performances were close to MCI patients. Indeed, SCD participants’ retrieval processes were impaired in visual modality, which paves the way to suggest that SCD, MCI, and AD patients present limited access of the memory trace or that they have not successfully encoded the information. Therefore, a disrupted attentional process might be partly indicative of the deficit particularly in VSTMT, presenting subtle connectivity alterations.

Moreover, in order to evaluate the potential use of these network metrics as biomarkers, we employed the ROC curve analysis to define the cut-off scores and the Sensitivity and Specificity of each metric (clustering coefficient, strength and betweenness centrality). Based on our findings, the clustering coefficient and strength during VAT have the potential to serve as markers for the detection of SCD, since they manage to distinguish SCD from HC with 71% Sensitivity and 65% Specificity (AUC = 71%, in ROC curves), MCI from HC with 71% Sensitivity and 61% Specificity (AUC = 71% and AUC = 70%, respectively, in VSTMT ROC curves), and AD from HC with 62% Sensitivity and 67% Specificity (AUC = 78% in ROC curves). An important finding deriving from the present study is that several SCD participants, that exhibited a similar neuropsychological profile with HC in the baseline examination but differed in brain network, demonstrated significant cognitive decline after three years compared to HC as revealed by the follow-up assessment. These findings suggest that people who present intermediate values to HC and MCI, may actually convert to MCI after 3 years. In detail, even before detecting decline in neuropsychological tests, network disruptions might show a common disconnection pattern of the brain connectome in SCD, although not to the same extent as in MCI. Moreover, the SCD group who converted to MCI and the MCI who presented worse performance or converted to AD had lower scores in the majority of neuropsychological assessment after three years compared to those who remained stable. Similarly, it has been demonstrated that cognitive measures can predict progression from MCI to Alzheimer’s type dementia/AD [11].

While a prevailing body of literature underlined impaired memory and execution in SCD and MCI population, our findings are in contrast with recent longitudinal studies supporting that neuropsychological assessment in elderly population demonstrates impairment of executive functions, memory, but not attention [52, 139, 140]. In a cross-sectional study [52], it was highlighted the existence of statistical significant differences with respect to selective and sustained attention in HC and SCD, whereas a subsequent longitudinal study concluded that the decline in simple sustained attention in MCI may be early precursors of future cognitive decline related to AD [140]. In this common vein, previous studies have demonstrated good performance in visual short-term memory tasks in asymptomatic cases, prior to the onset of dementia [55]. On the other hand, recent studies have demonstrated increased visual attention and memory errors in patients with AD [141–143], which are aligned with our results supporting that people with cognitive decline present extensive interruption with regards to brain connectome during visual attention and short-term memory tasks. Together, these findings provide growing support for the view that AD and its preclinical stages is associated with visual short-term memory impairments, and that lower performance in visual short-term memory related tasks might be an important signature of cognitive decline. In particular, a large part of the literature has suggested that lower test scores for memory is related to progression from MCI to AD [58]. The aforementioned research evidence is in line with our main findings that the visual attention and visual short-term memory may be vulnerable cognitive domains to early neurodegenerative process associated with SCD. Therefore, our clinical observations also supported this hypothesis, as SCD may frequently report frustration during handling work with more cognitive demands in other non-memory function, such as attention or information processing. Nevertheless, in a recent study, they explored the visual short-term memory deficits by comparing performance in patients with AD to a group of individuals with SCD [55]. SCD people, although mentioned decline in cognitive function, did not demonstrate objective clinical and cognitive changes at the time of the baseline assessment. Interestingly, compared to AD, SCD patients overall did not demonstrate any impairment in short-term retention of object-location bindings. In contrast with this study, our results showed statistically significant better performance in SCD group compared to AD but to lower extent than those of HC.

In line with previous research, we found apparent connections over the posterior regions of the brain during both tasks in people with SCD compared to HC. In particular, a recent study showed that SCD had decreased FC between the lingual gyrus, the left hippocampus and calcarine sulcus, which are areas that are basically involved in encoding visual memories [144, 145], and retrieval [99]. Therefore, interrupted FC between these brain regions could be indicative of poorer visual memory processing that impacts the subjective feeling of cognitive decline and might be also influenced by aging [50, 146, 147]. However, what decreasing FC between the primary visual cortex and other brain regions implies for SCD, is still under investigation, especially as direct connectivity between parietal regions and visual cortex is between in the dorsal and ventral brain areas [93, 148, 149]. Thus, decreased FC across the region of hippocampus and calcarine sulcus and lingual gyrus may reflect disrupted information transition to the hippocampus, indicating that cortical atrophy in visual regions may reflect AD, which is related to lower visuospatial ability and executive function [35, 54, 83, 150]. Thus, decreasing parietal to occipital FC in SCD, as we found in our study, strengthens support for SCD as a dementia precursor. Also, an important strength of the current study that relates to its design is the comparison of neuropsychological tests at baseline and 3-year follow-up, allowing us to derive the percentage of subjects that actually converted to a more advanced stage of AD, despite having a normal neuropsychological profile at baseline. In this way, we were able to quantify the benefit of having brain network properties measured during VAT and VSTMT that are capable of discriminating HC from SCD at baseline. Given that SCD were found to eventually convert in MCI with much higher percentage than HC, further advocates the potential of using EEG, after testing it in larger sample, as a tool for the early detection of people that may develop future cognitive decline so as to enable personalized and timely interventions. Although SCD is recognized as a high-risk status of AD with a normal cognitive level, which is earlier than the stage of MCI [151, 152], the conversion rate of SCD to MCI is 2.3% and 6.6% per year. However, a recent longitudinal neuroimaging study found that 31% of SCD progressed to MCI according to MRI and neuropsychological tests [153], while 52 out of 111 SCD remained stable. In our sample the conversion rate of 64.7% after 3 years follow-up can be explained also due to the fact that the participants were recruited from the outpatient clinics and day centers where the patients have an increased concern about their memory and cognitive ability instead of general public, given that community-based SCD subjects confer a much lower risk of progression to MCI over 3 years compared to clinical cohorts [154]. Therefore, the conversion of the SCD may not only due to cutting off sample sizes, insufficient follow-up time or could also misidentify many SCDs who could potentially convert to MCI, which could result in a highly mixed and heterogenous sSCD group, further reducing statistical power [153].

Nevertheless, several limitations should be reported in the present research study. The subject number was limited especially for AD, therefore raising concerns on whether the results might be biased by the small sample size. However, there are plenty of neurophysiological and brain connectome studies, which have used a similar number of participants or even smaller (12 SCD and 19 MCI [100]; 16 HC and 18 MCI [111]; 13 HC, 16 SCD, and 8 AD [155]; 9 HC and 14 MCI [156]; 16 MCI and 12 HC [157]). Therefore, we believe that given the complexity of conducting a neurophysiological brain connectome study in the patient population, the small number of participants might be a limitation but not a critical one that could mislead the results of the present study. Nevertheless, a possible future extension of this study could be the verification of the presented results in a larger sample including more participants from each stage. Moreover, another limitation of the study is that follow-up assessment was based solely on neuropsychological assessment and not on brain network properties. Thus, future longitudinal studies should focus on follow-up assessment of brain network properties on SCD subjects. This study highlights the importance of brain connectome during visual attention and visual short-term memory process to distinguish the subjects that are at higher from the ones that are at lower risk of developing cognitive decline in the future as a marker of preclinical AD. Further work is needed to examine additional task-specific factors, such as examining the same metrics after some time. Moreover, future studies could also explore Aβ markers or PIB-PET at baseline to investigate if they had any biomarkers of AD (i.e., cerebrospinal fluid amyloid or tau) or any information on the atrophy (like medial temporal lobe atrophy) or white matter hyperintensities (like Fazekas score) in the patients with SCD as compared with HC at baseline. That could strengthen the link between SCD and cognitive performance, as well as evaluating the extent to which other specific factors not examined in this study (e.g., genetic predisposition, volumetric properties of specific regions) may increase the association between SCD and brain networks markers as observed in this study. PCC was selected as a means to estimate connectivity between all pairs of electrodes. Power-based connectivity measurements, like PCC, have been examined by several studies [78, 148, 158, 159] with the scope of constructing weighted brain networks and this was the main reason we followed the same strategy here. Clearly, phase-based connectivity measurements such as weighted phase lag index (PLI), weighted PLI, or Spectral Coherence, could be also explored. This will in essence affect the network’s structure (i.e., phase-based and power-based measures of connectivity tend to reveal different patterns of connectivity), as the connectivity here is assumed to be instantaneous, while volume conduction issues must be also taken into consideration. Hence, phase-based connectivity measurements could be explored in any future extensions of this study as a means of verification but also as means to identify additional network properties that differ among the populations so as to measure connectivity such as Weighted Phased Lag Index [160], Phase Locking Value [161], and Granger Causality [162]. Further future work includes the RADAR-AD Tier 2 and Tier 3 study, which will take place at the CERTH-ITI Smart Home (https://smarthome.iti.gr), both utilizing EEG headbands. The Tier 2 study is already taking place in homes across European sites and utilized the DREEM EEG headband (https://dreem.com/). The Smart Home is a real living environment in Thessaloniki, Greece (https://smarthome.iti.gr/), equipped with a multitude of smart home sensors that monitor both environmental and behavioral parameters such as appliance usage and presence in rooms. The RADAR-AD Tier 3 study will involve healthy age-matched participants, SCD, and MCI to visit the Smart Home and take part in semi-directed as well as free living activities both during the day and during an overnight stay. They will use apps for assessment and intervention for AD and will be monitored by the sensors in order to investigate their suitability and performance as a testbed for future trials with MCI, SCD, and AD. Sensors will include portable EEG to explore similarities and differences to the present HD-EEG study, such as the capabilities and insights provided by the equipment as well as the acceptance and practicality of both applications. Additionally, the Muse EEG portable device will be employed so as to detect brain activity during mindfulness and resting state in people with SCD, MCI, and HC. As both studies include different EEG devices, both at home and at a home-like controlled environment, future work will explore similarities and differences, as well as the potential to transfer and compare the outcomes of the present HD-EEG study over to those applications. It will also explore the acceptance and practicality of these, more portable, applications.

Conclusions

This is the first ever reported study which investigates brain connectivity by using HD-EEG in order to explore network changes in SCD with regards to HC, MCI, and AD individuals while performing a VSTMT and VAT. Therefore, our study provides pieces of evidence that SCD may actually indicate a transitional preclinical stage of AD with network changes and brain connectome interruptions. HC presents a denser visual attention and short-term memory network with several connections between nodes at occipito-parietal electrodes regarding CC and S, whereas less connectivity between nodes (electrodes) in more advanced stages of AD was observed. The differences are more obvious during the visual attention, where the subjects must pay attention and encode the information. At 3-year follow-up examination, SCD showed worse performance in most of the neuropsychological tests compared to HC, while the MCI and AD also showed deterioration in almost all tests. Thus, considering the absence of any differentiation in the neuropsychological tests of HC and SCD at baseline, the ability of brain connectome analysis with EEG during VAT and VSTMT to differentiate between these groups can be considered particularly valuable.

ACKNOWLEDGMENTS

This research was funded by the RADAR-AD project, which has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 806999. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA (https://www.imi.europa.eu). This communication reflects the views of the RADAR-AD consortium and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained herein.

Authors’ disclosures available online (https://www.j-alz.com/manuscript-disclosures/21-5421r1).

SUPPLEMENTARY MATERIAL

[1] The supplementary material is available in the electronic version of this article: https://dx.doi.org/10.3233/JAD-215421.

REFERENCES

[1] 

((2021) ) 2021 Alzheimer’s disease facts and figures. Alzheimers Dement 17: , 327–406.

[2] 

Gauthier S , Reisberg B , Zaudig M , Petersen RC , Ritchie K , Broich K , Belleville S , Brodaty H , Bennett D , Chertkow H , Cummings JL , de Leon M , Feldman H , Ganguli M , Hampel H , Scheltens P , Tierney MC , Whitehouse P , Winblad B ((2006) ) Mild cognitive impairment. Lancet 367: , 1262–1270.

[3] 

Mohs RC , Knopman D , Petersen RC , Ferris SH , Ernesto C , Grundman M , Sano M , Bieliauskas L , Geldmacher D , Clark C , Thal LJ ((1997) ) Development of cognitive instruments for use in clinical trials of antidementia drugs: Additions to the Alzheimer’s disease assessment scale that broaden its scope. Alzheimer Dis Assoc Disord 11: , S13–21.

[4] 

Slot RER , Sikkes SAM , Berkhof J , Brodaty H , Buckley R , Cavedo E , Dardiotis E , Guillo-Benarous F , Hampel H , Kochan NA , Lista S , Luck T , Maruff P , Molinuevo JL , Kornhuber J , Reisberg B , Riedel-Heller SG , Risacher SL , Roehr S , Sachdev PS , Scarmeas N , Scheltens P , Shulman MB , Saykin AJ , Verfaillie SCJ , Visser PJ , Vos SJB , Wagner M , Wolfsgruber S , Jessen F , Boada M , de Deyn PP , Jones R , Frisoni G , Spiru L , Nobili F , Freund-Levi Y , Soininen H , Verhey F , Wallin ÅK , Touchon J , Rikkert MO , Rigaud AS , Bullock R , Tsolaki M , Vellas B , Wilcock G , Froelich L , Bakardjian H , Benali H , Bertin H , Bonheur J , Boukadida L , Boukerrou N , Chiesa P , Colliot O , Dubois B , Dubois M , Epelbaum S , Gagliardi G , Genthon R , Habert MO , Houot M , Kas A , Lamari F , Levy M , Metzinger C , Mochel F , Nyasse F , Poisson C , Potier MC , Revillon M , Santos A , Andrade KS , Sole M , Surtee M , Thiebaud de Schotten M , Vergallo A , Younsi N , van der Flier WM ((2019) ) Subjective cognitive decline and rates of incident Alzheimer’s disease and non-Alzheimer’s disease dementia. Alzheimers Dement 15: , 465–476.

[5] 

Verfaillie SCJ , Binette AP , Vachon-Presseau É , Tabrizi S , Savard M , Bellec P , Ossenkoppele R , Scheltens P , van der Flier WM , Breitner JCS , Villeneuve S ((2017) ) Subjective cognitive decline is associated with altered posterior cingulate connectivity in elderly with a familial history of Alzheimer’s disease. Alzheimers Dement 13: , P33–P34.

[6] 

Cheng Y-W , Chen T-F , Chiu M-J ((2017) ) From mild cognitive impairment to subjective cognitive decline: Conceptual and methodological evolution. Neuropsychiatr Dis Treat 13: , 491–498.

[7] 

Petersen RC , Morris JC ((2005) ) Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol 62: , 1160–3; discussion 1167.

[8] 

Liddell BJ , Paul RH , Arns M , Gordon N , Kukla M , Rowe D , Cooper N , Moyle J , Williams LM ((2007) ) Rates of decline distinguish Alzheimer’s disease and mild cognitive impairment relative to normal aging: Integrating cognition and brain function. J Integr Neurosci 6: , 141–174.

[9] 

Reisberg B , Shulman MB , Torossian C , Leng L , Zhu W ((2010) ) Outcome over seven years of healthy adults with and without subjective cognitive impairment. Alzheimers Dement 6: , 11–24.

[10] 

Garcia-Ptacek S , Eriksdotter M , Jelic V , Porta-Etessam J , Kåreholt I , Manzano Palomo S ((2016) ) Subjective cognitive impairment: Towards early identification of Alzheimer disease. Neurologia 31: , 562–571.

[11] 

Belleville S , Fouquet C , Hudon C , Zomahoun HTV , Croteau J ((2017) ) Neuropsychological measures that predict progression from mild cognitive impairment to Alzheimer’s type dementia in older adults: A systematic review and meta-analysis. Neuropsychol Rev 27: , 328–353.

[12] 

Mitchell AJ , Beaumont H , Ferguson D , Yadegarfar M , Stubbs B ((2014) ) Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: Meta-analysis. Acta Psychiatr Scand 130: , 439–451.

[13] 

Vlachos GS , Cosentino S , Kosmidis MH , Anastasiou CA , Yannakoulia M , Dardiotis E , Hadjigeorgiou G , Sakka P , Ntanasi E , Scarmeas N ((2019) ) Prevalence and determinants of subjective cognitive decline in a representative Greek elderly population. Int J Geriatr Psychiatry 34: , 846–854.

[14] 

Tales A , Jessen F , Butler C , Wilcock G , Phillips J , Bayer T ((2015) ) Subjective cognitive decline.S1-S. J Alzheimers Dis 48: , S1–S3.

[15] 

Schuck NW , Doeller CF , Polk TA , Lindenberger U , Li S-C ((2015) ) Human aging alters the neural computation and representation of space. Neuroimage I: , 141–150.

[16] 

Hearne LJ , Cocchi L , Zalesky A , Mattingley JB ((2017) ) Reconfiguration of brain network architectures between resting state and complexity-dependent cognitive reasoning. J Neurosci 37: , 8399–8411.

[17] 

Sander MC , Werkle-Bergner M , Lindenberger U ((2011) ) Contralateral delay activity reveals life-span age differences in top-down modulation of working memory contents. Cereb Cortex 21: , 2809–2819.

[18] 

McAvinue LP , Habekost T , Johnson KA , Kyllingsbæk S , Vangkilde S , Bundesen C , Robertson IH ((2012) ) Sustained attention, attentional selectivity, and attentional capacity across the lifespan. Atten Percept Psychophys 74: , 1570–1582.

[19] 

Greenwood PM , Parasuraman R , Haxby JV ((1993) ) Changes in visuospatial attention over the adult lifespan. Neuropsychologia 31: , 471–485.

[20] 

Park DC , Lautenschlager G , Hedden T , Davidson NS , Smith AD , Smith PK ((2002) ) Models of visuospatial and verbal memory across the adult life span. Psychol Aging 17: , 299–320.

[21] 

Cowan N , Elliott EM , Saults SJ , Morey CC , Mattox S , Hismjatullina A , Conway ARA ((2005) ) On the capacity of attention: Its estimation and its role in working memory and cognitive aptitudes. Cogn Psychol 51: , 42–100.

[22] 

Sarter M , Givens B , Bruno JP ((2001) ) The cognitive neuroscience of sustained attention: Where top-down meets bottom-up. Brain Res Brain Res Rev 35: , 146–160.

[23] 

Chun MM , Turk-Browne NB ((2007) ) Interactions between attention and memory. Curr Opin Neurobiol 17: , 177–184.

[24] 

Cowan N ((1999) ) An embedded-processes model of working memory. In Models of Working Memory: Mechanisms of Active Maintenance and Executive Control, Miyake A, Shah P, eds. Cambridge University Press, Cambridge; New York, pp. 62–101.

[25] 

Cowan N , Saults JS , Elliott EM ((2002) ) The search for what is fundamental in the development of working memory. Adv Child Dev Behav 29: , 1–49.

[26] 

Jonides J , Lacey SC , Nee DE ((2005) ) Processes of working memory in mind and brain. Curr Dir Psychol Sci 14: , 2–5.

[27] 

Pasternak T , Greenlee MW ((2005) ) Working memory in primate sensory systems. Nat Rev Neurosci 6: , 97–107.

[28] 

Druzgal TJ , D’Esposito M ((2001) ) Activity in fusiform face area modulated as a function of working memory load. Brain Res Cogn Brain Res 10: , 355–364.

[29] 

Postle BR ((2006) ) Working memory as an emergent property of the mind and brain. Neuroscience 139: , 23–38.

[30] 

Todd JJ , Marois R ((2004) ) Capacity limit of visual short-term memory in human posterior parietal cortex. Nature 428: , 751–754.

[31] 

Vogel EK , Machizawa MG ((2004) ) Neural activity predicts individual differences in visual working memory capacity. Nature 428: , 748–751.

[32] 

Minoshima S , Giordani B , Berent S , Frey KA , Foster NL , Kuhl DE ((1997) ) Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease. Ann Neurol 42: , 85–94.

[33] 

Silverman DH , Small GW , Chang CY , Lu CS , Kung De Aburto MA , Chen W , Czernin J , Rapoport SI , Pietrini P , Alexander GE , Schapiro MB , Jagust WJ , Hoffman JM , Welsh-Bohmer KA , Alavi A , Clark CM , Salmon E , de Leon MJ , Mielke R , Cummings JL , Kowell AP , Gambhir SS , Hoh CK , Phelps ME ((2001) ) Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA 286: , 2120–2127.

[34] 

Elfgren C , Gustafson L , Vestberg S , Risberg J , Rosen I , Ryding E , Passant U ((2003) ) Subjective experience of memory deficits related to clinical and neuroimaging findings. Dement Geriatr Cogn Disord 16: , 84–92.

[35] 

Zhou J , Greicius MD , Gennatas ED , Growdon ME , Jang JY , Rabinovici GD , Kramer JH , Weiner M , Miller BL , Seeley WW ((2010) ) Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer’s disease. Brain 133: , 1352–1367.

[36] 

López-Sanz D , Bruña R , Garcés P , Martín-Buro MC , Walter S , Delgado ML , Montenegro M , Higes RL , Marcos A , Maestú F ((2017) ) Functional connectivity disruption in subjective cognitive decline and mild cognitive impairment: A common pattern of alterations. Front Aging Neurosci 9: , 109.

[37] 

Greicius MD , Srivastava G , Reiss AL , Menon V ((2004) ) Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: Evidence from functional MRI. Proc Natl Acad Sci U S A 101: , 4637–4642.

[38] 

Lebedev MA , Messinger A , Kralik JD , Wise SP ((2004) ) Representation of attended versus remembered locations in prefrontal cortex. PLOS Biol 2: , e365.

[39] 

Motter BC ((1993) ) Focal attention produces spatially selective processing in visual cortical areas V1, V2, and V4 in the presence of competing stimuli. J Neurophysiol 70: , 909–919.

[40] 

Moran J , Desimone R ((1985) ) Selective attention gates visual processing in the extrastriate cortex. Science 229: , 782–784.

[41] 

Bisley JW , Goldberg ME ((2003) ) Neuronal activity in the lateral intraparietal area and spatial attention. Science 299: , 81–86.

[42] 

Ghose GM , Maunsell JHR ((2008) ) Spatial summation can explain the attentional modulation of neuronal responses to multiple stimuli in area V4. J Neurosci 28: , 5115–5126.

[43] 

Lee J , Maunsell JHR ((2010) ) Attentional modulation of MT neurons with single or multiple stimuli in their receptive fields. J Neurosci 30: , 3058–3066.

[44] 

Gunduz A , Brunner P , Daitch A , Leuthardt EC , Ritaccio AL , Pesaran B , Schalk G ((2011) ) Neural correlates of visual-spatial attention in electrocorticographic signals in humans. Front Hum Neurosci 5: , 89.

[45] 

Buschman TJ , Miller EK ((2007) ) Top-down versus bottom-up control of attention in the prefrontal and posterior parietal cortices. Science 315: , 1860–1864.

[46] 

Gregoriou GG , Gotts SJ , Zhou H , Desimone R ((2009) ) High-frequency, long-range coupling between prefrontal and visual cortex during attention. Science 324: , 1207–1210.

[47] 

Colby CL , Duhamel JR , Goldberg ME ((1996) ) Visual, presaccadic, and cognitive activation of single neurons in monkey lateral intraparietal area. J Neurophysiol 76: , 2841–2852.

[48] 

Gottlieb JP , Kusunoki M , Goldberg ME ((1998) ) The representation of visual salience in monkey parietal cortex. Nature 391: , 481–484.

[49] 

Goldberg ME , Bisley J , Powell KD , Gottlieb J , Kusunoki M ((2002) ) The role of the lateral intraparietal area of the monkey in the generation of saccades and visuospatial attention. Ann N Y Acad Sci 956: , 205–215.

[50] 

Uhlhaas PJ , Singer W ((2006) ) Neural synchrony in brain disorders: Relevance for cognitive dysfunctions and pathophysiology. Neuron 52: , 155–168.

[51] 

Kosmidou V , Tsolaki A , Papadaniil C , Tsolaki M , Hadjileontiadis L , Kompatsiaris I ((2014) ) Cognitive brain signal processing: Healthy vs Alzheimer’s disease patients. In Universal Access in Human-Computer Interaction. Design and Development Methods for Universal Access. UAHCI 2014. Lecture Notes in Computer Science, vol 8513, Stephanidis C, Antona M, eds. Springer, Cham, pp. 503–514.

[52] 

Saunders NLJ , Summers MJ ((2010) ) Attention and working memory deficits in mild cognitive impairment. J Clin Exp Neuropsychol 32: , 350–357.

[53] 

Baddeley AD , Baddeley HA , Bucks RS , Wilcock GK ((2001) ) Attentional control in Alzheimer’s disease. Brain 124: , 1492–1508.

[54] 

Alescio-Lautier B , Michel BF , Herrera C , Elahmadi A , Chambon C , Touzet C , Paban V ((2007) ) Visual and visuospatial short-term memory in mild cognitive impairment and Alzheimer disease: Role of attention. Neuropsychologia 45: , 1948–1960.

[55] 

Liang Y , Pertzov Y , Nicholas JM , Henley SMD , Crutch S , Woodward F , Leung K , Fox NC , Husain M ((2016) ) Visual short-term memory binding deficit in familial Alzheimer’s disease. Cortex 78: , 150–164.

[56] 

Bai F , Shu N , Yuan Y , Shi Y , Yu H , Wu D , Wang J , Xia M , He Y , Zhang Z ((2012) ) Topologically convergent and divergent structural connectivity patterns between patients with remitted geriatric depression and amnestic mild cognitive impairment. J Neurosci 32: , 4307–4318.

[57] 

Teipel S , Grothe MJ , Zhou J , Sepulcre J , Dyrba M , Sorg C , Babiloni C ((2016) ) Measuring cortical connectivity in Alzheimer’s disease as a brain neural network pathology: Toward clinical applications. J Int Neuropsychol Soc 22: , 138–163.

[58] 

Belleville S , Chertkow H , Gauthier S ((2007) ) Working memory and control of attention in persons with Alzheimer’s disease and mild cognitive impairment. Neuropsychology 21: , 458–469.

[59] 

Tales A , Haworth J , Nelson S , Snowden RJ , Wilcock G ((2005) ) Abnormal visual search in mild cognitive impairment and Alzheimer’s disease. Neurocase 11: , 80–84.

[60] 

Calderon J , Perry RJ , Erzinclioglu SW , Berrios GE , Dening TR , Hodges JR ((2001) ) Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer’s disease. J Neurol Neurosurg Psychiatry 70: , 157–164.

[61] 

Bundesen C ((1990) ) A theory of visual attention. Psychol Rev 97: , 523–547.

[62] 

Bundesen C , Habekost T , Kyllingsbæk S ((2005) ) A neural theory of visual attention: Bridging cognition and neurophysiology. Psychol Rev 112: , 291–328.

[63] 

Habekost T , Vogel A , Rostrup E , Bundesen C , Kyllingsbæk S , Garde E , Ryberg C , Waldemar G ((2013) ) Visual processing speed in old age. Scand J Psychol 54: , 89–94.

[64] 

Gunseli E , Olivers CNL , Meeter M ((2014) ) Effects of search difficulty on the selection, maintenance, and learning of attentional templates. J Cogn Neurosci 26: , 2042–2054.

[65] 

Fan J , Byrne J , Worden MS , Guise KG , McCandliss BD , Fossella J , Posner MI ((2007) ) The relation of brain oscillations to attentional networks. J Neurosci 27: , 6197–6206.

[66] 

Wiegand I , Töllner T , Dyrholm M , Müller HJ , Bundesen C , Finke K ((2014) ) Neural correlates of age-related decline and compensation in visual attention capacity. Neurobiol Aging 35: , 2161–2173.

[67] 

Vaessen MJ , Saj A , Lovblad K-O , Gschwind M , Vuilleumier P ((2016) ) Structural white-matter connections mediating distinct behavioral components of spatial neglect in right brain-damaged patients. Cortex 77: , 54–68.

[68] 

Cerami C , Crespi C , Della Rosa PA , Dodich A , Marcone A , Magnani G , Coppi E , Falini A , Cappa SF , Perani D ((2015) ) Brain changes within the visuo-spatial attentional network in posterior cortical atrophy. J Alzheimers Dis 43: , 385–395.

[69] 

Edin F , Klingberg T , Johansson P , McNab F , Tegnér J , Compte A ((2009) ) Mechanism for top-down control of working memory capacity. Proc Natl Acad Sci U S A 106: , 6802–6807.

[70] 

Hopfinger JB , Buonocore MH , Mangun GR ((2000) ) The neural mechanisms of top-down attentional control. Nat Neurosci 3: , 284–291.

[71] 

Corbetta M , Shulman GL ((2002) ) Control of goal-directed and stimulus-driven attention in the brain. Nat Rev Neurosci 3: , 201–215.

[72] 

Mantini D , Marzetti L , Corbetta M , Romani GL , Del Gratta C ((2010) ) Multimodal integration of fMRI and EEG data for high spatial and temporal resolution analysis of brain networks. Brain Topogr 23: , 150–158.

[73] 

Engemann DA , Gramfort A ((2015) ) Automated model selection in covariance estimation and spatial whitening of MEG and EEG signals. Neuroimage 108: , 328–342.

[74] 

Rellecke J , Sommer W , Schacht A ((2013) ) Emotion effects on the n170: A question of reference? Brain Topogr 26: , 62–71.

[75] 

Vogel EK , Luck SJ ((2000) ) The visual N1 component as an index of a discrimination process. Psychophysiology 37: , 190–203.

[76] 

Nishifuji S , Kuroda T (2012) Impact of mental focus on steady-state visually evoked potential under eyes closed condition for binary brain computer interface. 2012 Annual International Conference of the IEEE Engineering in Medicine and Biology Soceity, pp. 1765-1768.

[77] 

Grossi D , Fasanaro AM , Cecere R , Salzano S , Trojano L ((2007) ) Progressive topographical disorientation: A case of focal Alzheimer’s disease. Neurol Sci 28: , 107–110.

[78] 

Franzmeier N , Düzel E , Jessen F , Buerger K , Levin J , Duering M , Dichgans M , Haass C , Suárez-Calvet M , Fagan AM , Paumier K , Benzinger T , Masters CL , Morris JC , Perneczky R , Janowitz D , Catak C , Wolfsgruber S , Wagner M , Teipel S , Kilimann I , Ramirez A , Rossor M , Jucker M , Chhatwal J , Spottke A , Boecker H , Brosseron F , Falkai P , Fliessbach K , Heneka MT , Laske C , Nestor P , Peters O , Fuentes M , Menne F , Priller J , Spruth EJ , Franke C , Schneider A , Kofler B , Westerteicher C , Speck O , Wiltfang J , Bartels C , Araque Caballero MÁ , Metzger C , Bittner D , Weiner M , Lee JH , Salloway S , Danek A , Goate A , Schofield PR , Bateman RJ , Ewers M ((2018) ) Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer’s disease. Brain 141: , 1186–1200.

[79] 

Hosseini SMH , Kramer JH , Kesler SR ((2014) ) Neural correlates of cognitive intervention in persons at risk of developing Alzheimer’s disease. Front Aging Neurosci 6: , 231.

[80] 

Basso M , Yang J , Warren L , MacAvoy MG , Varma P , Bronen RA , van Dyck CH ((2006) ) Volumetry of amygdala and hippocampus and memory performance in Alzheimer’s disease. Psychiatry Res 146: , 251–261.

[81] 

Fujimori M , Imamura T , Hirono N , Ishii K , Sasaki M , Mori E ((2000) ) Disturbances of spatial vision and object vision correlate differently with regional cerebral glucose metabolism in Alzheimer’s disease. Neuropsychologia 38: , 1356–1361.

[82] 

Worbe Y ((2015) ) Neuroimaging signature of neuropsychiatric disorders. Curr Opin Neurol 28: , 358–364.

[83] 

Dannhauser TM , Walker Z , Stevens T , Lee L , Seal M , Shergill SS ((2005) ) The functional anatomy of divided attention in amnestic mild cognitive impairment. Brain 128: , 1418–1427.

[84] 

Beason-Held LL ((2011) ) Dementia and the default mode. Curr Alzheimer Res 8: , 361–365.

[85] 

Poza J , Garcia M , Gomez C , Bachiller A , Carreres A , Hornero R (2013) Characterization of the spontaneous electroencephalographic activity in Alzheimer’s disease using disequilibria and graph theory. 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), pp. 5990-5993.

[86] 

Lo C-Y , Wang P-N , Chou K-H , Wang J , He Y , Lin C-P ((2010) ) Diffusion tensor tractography reveals abnormal topological organization in structural cortical networks in Alzheimer’s disease. J Neurosci 30: , 16876–16885.

[87] 

Wen W , He Y , Sachdev P ((2011) ) Structural brain networks and neuropsychiatric disorders. Curr Opin Psychiatry 24: , 219–225.

[88] 

Miraglia F , Vecchio F , Rossini PM ((2017) ) Searching for signs of aging and dementia in EEG through network analysis. Behav Brain Res. 317: , 292–300.

[89] 

Sun J , Tong S , Yang G-Y ((2012) ) Reorganization of brain networks in aging and age-related diseases. Aging Dis 3: , 181–193.

[90] 

Brier MR , Thomas JB , Fagan AM , Hassenstab J , Holtzman DM , Benzinger TL , Morris JC , Ances BM ((2014) ) Functional connectivity and graph theory in preclinical Alzheimer’s disease. Neurobiol Aging 35: , 757–768.

[91] 

Wang CL , Pan Y , Liu YM , Xu K , Hao LX , Huang F , Ke J , Sheng LQ , Ma HR , Guo WF ((2018) ) Aberrant default mode network in amnestic mild cognitive impairment: A meta-analysis of independent component analysis studies. Neurol Sci 39: , 919–931.

[92] 

Li S , Ma X , Huang R , Li M , Tian J , Wen H , Lin C , Wang T , Zhan W , Fang J , Jiang G ((2015) ) Abnormal degree centrality in neurologically asymptomatic patients with end-stage renal disease: A resting-state fMRI study. Clin Neurophysiol 127: , 602–609.

[93] 

Lazarou I , Georgiadis K , Nikolopoulos S , Oikonomou VP , Tsolaki A , Kompatsiaris I , Tsolaki M , Kugiumtzis D ((2020) ) A novel connectome-based electrophysiological study of subjective cognitive decline related to Alzheimer’s disease by using resting-state high-density EEG EGI GES 300. Brain Sci 10: , 392.

[94] 

Lazarou I , Nikolopoulos S , Dimitriadis SI , (Yiannis) Kompatsiaris I , Spilioti M , Tsolaki M ((2019) ) Is brain connectome research the future frontier for subjective cognitive decline? A systematic review. Clin Neurophysiol 130: , 1762–1780.

[95] 

Yan T , Wang W , Yang L , Chen K , Chen R , Han Y ((2018) ) Rich club disturbances of the human connectome from subjective cognitive decline to Alzheimer’s disease. Theranostics 8: , 3237–3255.

[96] 

Lopez-Larraz E , Montesano L , Gil-Agudo A , Minguez J ((2014) ) Continuous decoding of movement intention of upper limb self-initiated analytic movements from pre-movement EEG correlates. J Neuroeng Rehabil 11: , 153.

[97] 

Garcés P , Ángel Pineda-Pardo J , Canuet L , Aurtenetxe S , López ME , Marcos A , Yus M , Llanero-Luque M , Del-Pozo F , Sancho M , Maestú F ((2014) ) The default mode network is functionally and structurally disrupted in amnestic mild cognitive impairment-A bimodal MEG-DTI study. Neuroimage Clin 6: , 214–221.

[98] 

Wiegand I , Lauritzen MJ , Osler M , Mortensen EL , Rostrup E , Rask L , Richard N , Horwitz A , Benedek K , Vangkilde S , Petersen A ((2018) ) EEG correlates of visual short-term memory in older age vary with adult lifespan cognitive development. Neurobiol Aging 62: , 210–220.

[99] 

Tu MC , Lo CP , Huang CF , Huang WH , Deng JF , Hsu YH ((2018) ) Visual attention performances and related cerebral microstructural integrity among subjects with subjective cognitive decline and mild cognitive impairment. Front Aging Neurosci 10: , 268.

[100] 

Bajo R , Castellanos NP , López ME , Ruiz JM , Montejo P , Montenegro M , Llanero M , Gil P , Yubero R , Baykova E , Paul N , Aurtenetxe S , Del Pozo F , Maestu F ((2012) ) Early dysfunction of functional connectivity in healthy elderly with subjective memory complaints. Age (Omaha) 34: , 497–506.

[101] 

Babiloni C , Binetti G , Cassetta E , Forno GD , Percio Del C , Ferreri F , Ferri R , Frisoni G , Hirata K , Lanuzza B , Miniussi C , Moretti DV , Nobili F , Rodriguez G , Romani GL , Salinari S , Rossini PM ((2006) ) Sources of cortical rhythms change as a function of cognitive impairment in pathological aging: A multicenter study. Clin Neurophysiol 117: , 252–268.

[102] 

Koenig T , Prichep L , Dierks T , Hubl D , Wahlund LO , John ER , Jelic V ((2005) ) Decreased EEG synchronization in Alzheimer’s disease and mild cognitive impairment. Neurobiol Aging 26: , 165–171.

[103] 

Jalili M ((2016) ) Functional brain networks: Does the choice of dependency estimator and binarization method matter? Sci Rep 6: , 29780.

[104] 

Babiloni C , Visser PJ , Frisoni G , De Deyn PP , Bresciani L , Jelic V , Nagels G , Rodriguez G , Rossini PM , Vecchio F , Colombo D , Verhey F , Wahlund LO , Nobili F ((2010) ) Cortical sources of resting EEG rhythms in mild cognitive impairment and subjective memory complaint. Neurobiol Aging 31: , 1787–1798.

[105] 

Choi K-M , Kim J-Y , Kim Y-W , Han J-W , Im C-H , Lee S-H ((2021) ) Comparative analysis of default mode networks in major psychiatric disorders using resting-state EEG. Sci Rep 11: , 22007.

[106] 

Chen Y , Tang JH , De Stefano LA , Wenger MJ , Ding L , Craft MA , Carlson BW , Yuan H ((2022) ) Electrophysiological resting state brain network and episodic memory in healthy aging adults. Neuroimage 253: , 118926.

[107] 

Dumitrescu C , Costea I-M , Cormos A-C , Semenescu A ((2021) ) Automatic detection of K-complexes using the Cohen class recursiveness and reallocation method and deep neural networks with EEG signals. Sensors (Basel) 21: , 7230.

[108] 

Dauwels J , Vialatte F , Musha T , Cichocki A ((2010) ) A comparative study of synchrony measures for the early diagnosis of Alzheimer’s disease based on EEG. Neuroimage 49: , 668–693.

[109] 

Dimitriadis SI , Tarnanas I , Wiederhold M , Wiederhold B , Tsolaki M , Fleisch E ((2016) ) Mnemonic strategy training of the elderly at risk for dementia enhances integration of information processing via cross-frequency coupling. Alzheimers Dement (N Y) 2: , 241–249.

[110] 

Hafkemeijer A , Altmann-Schneider I , Oleksik AM , van de Wiel L , Middelkoop HAM , van Buchem MA , van der Grond J , Rombouts SARB ((2013) ) Increased functional connectivity and brain atrophy in elderly with subjective memory complaints. Brain Connect 3: , 353–362.

[111] 

Wang Y , Risacher SL , West JD , McDonald BC , MaGee TR , Farlow MR , Gao S , O’Neill DP , Saykin AJ ((2013) ) Altered default mode connectivity in older adults with cognitive complaints and amnestic mild cognitive impairment. J Alzheimers Dis 35: , 751–760.

[112] 

Georgiadis K , Laskaris N , Nikolopoulos S , Kompatsiaris I ((2018) ) Exploiting the heightened phase synchrony in patients with neuromuscular disease for the establishment of efficient motor imagery BCIs. J Neuroeng Rehabil 15: , 90.

[113] 

Koedam ELGE , Lauffer V , Van Der Vlies AE , Van Der Flier WM , Scheltens P , Pijnenburg YAL ((2010) ) Early-versus late-onset Alzheimer’s disease: More than age alone. J Alzheimers Dis 19: , 1401–1408.

[114] 

Noble JM , Scarmeas N ((2008) ) Cognitive impairment. In Improving Oral Health for the Elderly, Lamster IB, Northridge ME, eds. Springer, NY, pp. 99–126.

[115] 

Pierce AL , Bullain SS , Kawas CH ((2017) ) Late-onset Alzheimer disease. Neurol Clin 35: , 283–293.

[116] 

McKhann G , Drachman D , Folstein M , Katzman R , Price D , Stadlan EM ((1984) ) Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34: , 939–944.

[117] 

Petersen RC , Knopman DS , Boeve BF , Geda YE , Ivnik RJ , Smith GE , Roberts RO , Jack CR ((2009) ) Mild cognitive impairment: Ten years later. Arch Neurol 66: , 1447–1455.

[118] 

Dubois B , Feldman HH , Jacova C , Hampel H , Molinuevo JL , Blennow K , DeKosky ST , Gauthier S , Selkoe D , Bateman R , Cappa S , Crutch S , Engelborghs S , Frisoni GB , Fox NC , Galasko D , Habert M-O , Jicha GA , Nordberg A , Pasquier F , Rabinovici G , Robert P , Rowe C , Salloway S , Sarazin M , Epelbaum S , de Souza LC , Vellas B , Visser PJ , Schneider L , Stern Y , Scheltens P , Cummings JL ((2014) ) Advancing research diagnostic criteria for Alzheimer’s disease: The IWG-2 criteria. Lancet Neurol 13: , 614–629.

[119] 

Molinuevo JL , Rabin LA , Amariglio R , Buckley R , Dubois B , Ellis KA , Ewers M , Hampel H , Klöppel S , Rami L , Reisberg B , Saykin AJ , Sikkes S , Smart CM , Snitz BE , Sperling R , van der Flier WM , Wagner M , Jessen F ((2017) ) Implementation of subjective cognitive decline criteria in research studies. Alzheimers Dement 13: , 296–311.

[120] 

First MB et , Spitzer RL , Gibbon M , Williams JBW (1997) Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV).

[121] 

Folstein MF , Folstein SE , McHugh PR ((1975) ) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: , 189–198.

[122] 

Hutton JT ((1987) ) Alzheimer’s disease. Tex Med 83: , 6–7.

[123] 

Kounti F , Tsolaki M , Kiosseoglou G ((2006) ) Functional cognitive assessment scale (FUCAS): A new scale to assess executive cognitive function in daily life activities in patients with dementia and mild cognitive impairment. Hum Psychopharmacol 21: , 305–311.

[124] 

Tombaugh T ((2004) ) Trail Making Test A and B: Normative data stratified by age and education. Arch Clin Neuropsychol 19: , 203–214.

[125] 

Wilson B , Cockburn J , Baddeley A , Hiorns R ((1989) ) The development and validation of a test battery for detecting and monitoring everyday memory problems. J Clin Exp Neuropsychol 11: , 855–870.

[126] 

Osterrieth PA ((1944) ) Le test de copie d’une figure complexe; contribution à l’étude de la perception et de la mémoire. [Test of copying a complex figure; contribution to the study of perception and memory]. Arch Psychol (Geneve) 30: , 206–356.

[127] 

Cummings JL , Mega M , Gray K , Rosenberg-Thompson S , Carusi DA , Gornbein J ((1994) ) The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 44: , 2308–2314.

[128] 

Cohen S , Kamarck T , Mermelstein R ((1983) ) A global measure of perceived stress. J Health Soc Behav 24: , 385–396.

[129] 

Ferree TC , Luu P , Russell GS , Tucker DM ((2001) ) Scalp electrode impedance, infection risk, and EEG data quality. Clin Neurophysiol 112: , 536–544.

[130] 

Coull JT , Frith CD , Frackowiak RS , Grasby PM ((1996) ) A fronto-parietal network for rapid visual information processing: A PET study of sustained attention and working memory. Neuropsychologia 34: , 1085–1095.

[131] 

Ray KL , Ragland JD , MacDonald AW , Gold JM , Silverstein SM , Barch DM , Carter CS ((2020) ) Dynamic reorganization of the frontal parietal network during cognitive control and episodic memory. Cogn Affect Behav Neurosci 20: , 76–90.

[132] 

Figueroa-Vargas A , Cárcamo C , Henríquez-Ch R , Zamorano F , Ciampi E , Uribe-San-Martin R , Vásquez M , Aboitiz F , Billeke P ((2020) ) Frontoparietal connectivity correlates with working memory performance in multiple sclerosis. Sci Rep 10: , 9310.

[133] 

Christophe TB , Hebart MN , Haynes JD ((2012) ) Decoding the contents of visual short-term memory from human visual and parietal cortex. J Neurosci 32: , 12983–12989.

[134] 

Sheremata SL , Somers DC , Shomstein S ((2018) ) Visual short-term memory activity in parietal lobe reflects cognitive processes beyond attentional selection. J Neurosci 38: , 1511–1519.

[135] 

Electrical Geodesics Inc. (2007) Geodesic Sensor Net Technical Manual, pp. 1-150.

[136] 

Georgiadis K , Laskaris N , Nikolopoulos S , Kompatsiaris I ((2019) ) Connectivity steered graph Fourier transform for motor imagery BCI decoding. J Neural Eng 16: , 56021.

[137] 

Georgiadis K , Adamos DA , Nikolopoulos S , Laskaris N , Kompatsiaris I ((2021) ) Covariation informed graph slepians for motor imagery decoding. IEEE Trans Neural Syst Rehabil Eng 29: , 340–349.

[138] 

Rubinov M , Sporns O ((2010) ) Complex network measures of brain connectivity: Uses and interpretations. Neuroimage 52: , 1059–1069.

[139] 

Elkana O , Eisikovits OR , Oren N , Betzale V , Giladi N , Ash EL ((2016) ) Sensitivity of neuropsychological tests to identify cognitive decline in highly educated elderly individuals: 12 months follow up. J Alzheimers Dis 49: , 607–616.

[140] 

Saunders NLJ , Summers MJ ((2011) ) Longitudinal deficits to attention, executive, and working memory in subtypes of mild cognitive impairment. Neuropsychology 25: , 237–248.

[141] 

Peich MC , Husain M , Bays PM ((2013) ) Age-related decline of precision and binding in visual working memory. Psychol Aging 28: , 729–743.

[142] 

Guazzo F , Allen RJ , Baddeley AD , Della Sala S ((2020) ) Unimodal and crossmodal working memory binding is not differentially affected by age or Alzheimer’s disease. Neuropsychology 34: , 420–436.

[143] 

Parra MA , Abrahams S , Fabi K , Logie R , Luzzi S , Della Sala S ((2009) ) Short-term memory binding deficits in Alzheimer’s disease. Brain 132: , 1057–1066.

[144] 

Dillen KNH , Jacobs HIL , Kukolja J , von Reutern B , Richter N , Onur ÖA , Dronse J , Langen KJ , Fink GR ((2016) ) Aberrant functional connectivity differentiates retrosplenial cortex from posterior cingulate cortex in prodromal Alzheimer’s disease. Neurobiol Aging 44: , 114–126.

[145] 

Wang X-N , Zeng Y , Chen G-Q , Zhang Y-H , Li X-Y , Hao X-Y , Yu Y , Zhang M , Sheng C , Li Y-X , Sun Y , Li H-Y , Song Y , Li K-C , Yan T-Y , Tang X-Y , Han Y ((2016) ) Abnormal organization of white matter networks in patients with subjective cognitive decline and mild cognitive impairment. Oncotarget 7: , 48953–48962.

[146] 

Borghesani PR , Johnson LC , Shelton AL , Peskind ER , Aylward EH , Schellenberg GD , Cherrier MM ((2008) ) Altered medial temporal lobe responses during visuospatial encoding in healthy APOE*4 carriers. Neurobiol Aging 29: , 981–991.

[147] 

Jenkins A , Tree JJ , Thornton IM , Tales A ((2019) ) Subjective cognitive impairment in 55-65-year-old adults is associated with negative affective symptoms, neuroticism, and poor quality of life. J Alzheimers Dis 67: , 1367–1378.

[148] 

Dillen KNH , Jacobs HIL , Kukolja J , Richter N , Von Reutern B , Onur ÖA , Langen KJ , Fink GR ((2017) ) Functional disintegration of the default mode network in prodromal Alzheimer’s disease. J Alzheimers Dis 59: , 169–187.

[149] 

Selnes P , Fjell AM , Gjerstad L , Bjornerud A , Wallin A , Due-Tonnessen P , Grambaite R , Stenset V , Fladby T ((2012) ) White matter imaging changes in subjective and mild cognitive impairment. Alzheimers Dement 8: , S112–S121.

[150] 

Rombouts SARB , Barkhof F , Goekoop R , Stam CJ , Scheltens P ((2005) ) Altered resting state networks in mild cognitive impairment and mild Alzheimer’s disease: An fMRI study. Hum Brain Mapp 26: , 231–239.

[151] 

Wolfsgruber S , Polcher A , Koppara A , Kleineidam L , Frölich L , Peters O , Hüll M , Rüther E , Wiltfang J , Maier W , Kornhuber J , Lewczuk P , Jessen F , Wagner M ((2017) ) Cerebrospinal fluid biomarkers and clinical progression in patients with subjective cognitive decline and mild cognitive impairment. J Alzheimers Dis 58: , 939–950.

[152] 

Yue L , Hu D , Zhang H , Wen J , Wu Y , Li W , Sun L , Li X , Wang J , Li G , Wang T , Shen D , Xiao S ((2021) ) Prediction of 7-year’s conversion from subjective cognitive decline to mild cognitive impairment. Hum Brain Mapp 42: , 192–203.

[153] 

Snitz BE , Wang T , Cloonan YK , Jacobsen E , Chang CCH , Hughes TF , Kamboh MI , Ganguli M ((2018) ) Risk of progression from subjective cognitive decline to mild cognitive impairment: The role of study setting. Alzheimers Dement 14: , 734–742.

[154] 

Contreras JA , Goñi J , Risacher SL , Amico E , Yoder K , Dzemidzic M , West JD , McDonald BC , Farlow MR , Sporns O , Saykin AJ ((2017) ) Cognitive complaints in older adults at risk for Alzheimer’s disease are associated with altered resting-state networks. Alzheimers Dement (Amst) 6: , 40–49.

[155] 

Tóth B , File B , Boha R , Kardos Z , Hidasi Z , Gaál ZA , Csibri É , Salacz P , Stam CJ , Molnár M ((2014) ) EEG network connectivity changes in mild cognitive impairment - Preliminary results. Int J Psychophysiol 92: , 1–7.

[156] 

Zeng K , Wang Y , Ouyang G , Bian Z , Wang L , Li X ((2015) ) Complex network analysis of resting state EEG in amnestic mild cognitive impairment patients with type 2 diabetes. Front Comput Neurosci 9: , 133.

[157] 

López-Sanz D , Garcés P , Álvarez B , Delgado-Losada ML , López-Higes R , Maestú F ((2017) ) Network disruption in the preclinical stages of Alzheimer’s disease: From subjective cognitive decline to mild cognitive impairment. Int J Neural Syst 27: , 1750041.

[158] 

Study C , Hao Y , Cheng F , Pham M , Rein H , Patel D , Fang Y ((2019) ) A noninvasive, economical, and instant-result method to diagnose and monitor type 2 diabetes using pulse wave. JMIR mHealth uHealth 7: , 1–11.

[159] 

Vinck M , Oostenveld R , van Wingerden M , Battaglia F , Pennartz CMA ((2011) ) An improved index of phase-synchronization for electrophysiological data in the presence of volume-conduction, noise and sample-size bias. Neuroimage 55: , 1548–1565.

[160] 

Lachaux JP , Rodriguez E , Martinerie J , Varela FJ ((1999) ) Measuring phase synchrony in brain signals. Hum Brain Mapp 8: , 194–208.

[161] 

Barnett L , Seth AK ((2014) ) The MVGC multivariate Granger causality toolbox: A new approach to Granger-causal inference. J Neurosci Methods 223: , 50–68.